Biologics
New Cost Effectiveness Data for Bone Growth Peptide
New Drug Family Targets Dupuytren’s, Frozen Shoulder
Outcomes Registry Data for Regenerative Treatments
Living Progenitor Cells Edge Closer to “Cure-all” Status
Novel Bioresorbable Alloy Could Lead to Temporary Implants
75 COVID Vaccine Candidates – Winner Is?
